Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial

Launched by NATIONAL CANCER INSTITUTE (NCI) · Jun 19, 2006

Keywords

ClinConnect Summary

The PLCO Cancer Screening Trial is a research study aimed at finding out how effective screening tests are for four types of cancer: prostate, lung, colorectal (colon), and ovarian cancer. The study includes about 74,000 men and 74,000 women aged 55 to 74 years, who are divided into two groups. One group receives regular cancer screenings, while the other group continues with their usual healthcare without additional screenings. Researchers will collect blood and saliva samples from participants and gather information about their health and any cancers that may develop over time.

To participate, individuals must be between 55 and 74 years old and should not have a history of the cancers being studied or have had routine cancer screenings before. While participants in the study may not receive individual results from the additional tests, they can ask for their test results if they want. The study is currently active but not looking for new participants. It's important to know that even if someone doesn't consent to share personal information with the study's data center, they will still be monitored through state cancer registries.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Men and women aged 55-74 years.
• • Subjects who do not have a prior history of PLCO tumors and have not undergone routine screening.